Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients
Background The launch of imatinib has turned chronic myeloid leukaemia (CML) into a chronic illness due to the dramatic improvement in survival. Several recent studies have demonstrated that poor adherence to imatinib may hamper the therapeutic outcomes and result in increased medical expenditures,...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Netherlands
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890041/ |